Dare Bioscience Analyst Ratings
Dare Bioscience Analyst Ratings
While ratings are subjective and will change, the latest Dare Bioscience (DARE) rating was a maintained with a price target of $7.00 to $6.00. The current price Dare Bioscience (DARE) is trading at is $0.36, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/10/2023 | 1570.38% | HC Wainwright & Co. | $7 → $6 | Maintains | Buy |
| 08/11/2023 | 1848.78% | HC Wainwright & Co. | → $7 | Reiterates | Buy → Buy |
| 07/13/2023 | 1848.78% | HC Wainwright & Co. | → $7 | Reiterates | Buy → Buy |
| 06/06/2023 | 1848.78% | HC Wainwright & Co. | → $7 | Reiterates | → Buy |
| 05/22/2023 | 1848.78% | HC Wainwright & Co. | → $7 | Reiterates | Buy → Buy |
| 05/12/2023 | 1848.78% | HC Wainwright & Co. | → $7 | Reiterates | Buy → Buy |
| 03/31/2023 | 1848.78% | HC Wainwright & Co. | → $7 | Reiterates | → Buy |
| 12/13/2022 | 1848.78% | HC Wainwright & Co. | $6 → $7 | Maintains | Buy |
| 12/01/2022 | 1570.38% | JonesTrading | → $6 | Initiates Coverage On | → Buy |
| 04/01/2022 | 1570.38% | HC Wainwright & Co. | $5 → $6 | Maintains | Buy |
| 06/30/2021 | 2962.36% | Roth Capital | $9 → $11 | Maintains | Buy |
| 12/18/2020 | 1291.98% | HC Wainwright & Co. | → $5 | Initiates Coverage On | → Buy |
| 04/28/2020 | 1987.97% | Brookline Capital | → $7.5 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析師事務所 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 11/10/2023 | 1570.38% | HC Wainwright & Co. | 7 美元 → 6 美元 | 維護 | 購買 |
| 08/11/2023 | 1848.78% | HC Wainwright & Co. | → 7 美元 | 重申 | 購買 → 購買 |
| 07/13/2023 | 1848.78% | HC Wainwright & Co. | → 7 美元 | 重申 | 購買 → 購買 |
| 06/06/2023 | 1848.78% | HC Wainwright & Co. | → 7 美元 | 重申 | → 購買 |
| 05/22/2023 | 1848.78% | HC Wainwright & Co. | → 7 美元 | 重申 | 購買 → 購買 |
| 05/12/2023 | 1848.78% | HC Wainwright & Co. | → 7 美元 | 重申 | 購買 → 購買 |
| 03/31/2023 | 1848.78% | HC Wainwright & Co. | → 7 美元 | 重申 | → 購買 |
| 12/13/2022 | 1848.78% | HC Wainwright & Co. | 6 美元 → 7 美元 | 維護 | 購買 |
| 2022 年 1 月 12 日 | 1570.38% | JonesTrading | → 6 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 04/01/2022 | 1570.38% | HC Wainwright & Co. | 5 美元 → 6 美元 | 維護 | 購買 |
| 2021 年 6 月 30 日 | 2962.36% | 羅斯資本 | 9 美元 → 11 美元 | 維護 | 購買 |
| 2020 年 12 月 18 日 | 1291.98% | HC Wainwright & Co. | → 5 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 04/28/2020 | 1987.97% | 布魯克林資本 | → 7.5 美元 | 啓動覆蓋範圍開啓 | → 購買 |
What is the target price for Dare Bioscience (DARE)?
Dare Bioscience（DARE）的目標價格是多少？
The latest price target for Dare Bioscience (NASDAQ: DARE) was reported by HC Wainwright & Co. on November 10, 2023. The analyst firm set a price target for $6.00 expecting DARE to rise to within 12 months (a possible 1570.38% upside). 9 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 於2023年11月10日公佈了Dare Bioscience（納斯達克股票代碼：DARE）的最新目標股價。該分析公司將目標股價定爲6.00美元，預計DARE將在12個月內上漲至6.00美元（可能上漲1570.38％）。去年有9家分析公司公佈了評級。
What is the most recent analyst rating for Dare Bioscience (DARE)?
Dare Bioscience（DARE）的最新分析師評級是多少？
The latest analyst rating for Dare Bioscience (NASDAQ: DARE) was provided by HC Wainwright & Co., and Dare Bioscience maintained their buy rating.
Dare Bioscience（納斯達克股票代碼：DARE）的最新分析師評級由HC Wainwright & Co. 提供，Dare Bioscience維持其買入評級。
When is the next analyst rating going to be posted or updated for Dare Bioscience (DARE)?
Dare Bioscience（DARE）的下一個分析師評級何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Dare Bioscience, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Dare Bioscience was filed on November 10, 2023 so you should expect the next rating to be made available sometime around November 10, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與Dare Bioscience的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月進行一次評級，因此每家公司每年應獲得4個評級。Dare Bioscience的最後一次評級是在2023年11月10日提交的，因此您應該預計下一個評級將在2024年11月10日左右公佈。
Is the Analyst Rating Dare Bioscience (DARE) correct?
分析師對Dare Bioscience（DARE）的評級是否正確？
While ratings are subjective and will change, the latest Dare Bioscience (DARE) rating was a maintained with a price target of $7.00 to $6.00. The current price Dare Bioscience (DARE) is trading at is $0.36, which is out of the analyst's predicted range.
儘管評級是主觀的，並將發生變化，但最新的大膽生物科學（DARE）評級維持不變，目標股價爲7.00美元至6.00美元。Dare Bioscience（DARE）目前的交易價格爲0.36美元，超出了分析師的預測區間。